Idiopathic thrombocytopenic purpura and MMR vaccine
- PMID: 11207170
- PMCID: PMC1718684
- DOI: 10.1136/adc.84.3.227
Idiopathic thrombocytopenic purpura and MMR vaccine
Abstract
A CAUSAL ASSOCIATION BETWEEN MEASLES: mumps-rubella (MMR) vaccine and idiopathic thrombocytopenic purpura (ITP) was confirmed using immunisation/hospital admission record linkage. The absolute risk within six weeks of immunisation was 1 in 22 300 doses, with two of every three cases occurring in the six week post-immunisation period being caused by MMR. Children with ITP before MMR had no vaccine associated recurrences.
Similar articles
-
A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.Lancet. 1995 Mar 4;345(8949):567-9. doi: 10.1016/s0140-6736(95)90471-9. Lancet. 1995. PMID: 7619183
-
MMR vaccine and idiopathic thrombocytopaenic purpura.Br J Clin Pharmacol. 2003 Jan;55(1):107-11. doi: 10.1046/j.1365-2125.2003.01790.x. Br J Clin Pharmacol. 2003. PMID: 12534647 Free PMC article.
-
Vaccine administration and the development of immune thrombocytopenic purpura in children.Hum Vaccin Immunother. 2013 May;9(5):1158-62. doi: 10.4161/hv.23601. Epub 2013 Jan 16. Hum Vaccin Immunother. 2013. PMID: 23324619 Free PMC article. Review.
-
Is MMR immunisation safe in chronic Idiopathic thrombocytopenic purpura?Arch Dis Child. 2008 Apr;93(4):354-5. doi: 10.1136/adc.2007.132340. Arch Dis Child. 2008. PMID: 18356391 No abstract available.
-
Measles-mumps-rubella vaccination induced thrombocytopenia: a case report and review of the literature.Southeast Asian J Trop Med Public Health. 2014 Sep;45(5):1053-7. Southeast Asian J Trop Med Public Health. 2014. PMID: 25417506 Review.
Cited by
-
Frequently asked questions on seven rare adverse events following immunization.J Prev Med Hyg. 2017 Mar;58(1):E13-E26. J Prev Med Hyg. 2017. PMID: 28515627 Free PMC article. Review.
-
Adverse events following Measles-Mumps-Rubella and varicella immunization: A safety profile analysis and comparison of different vaccination schedules based on the Italian Pharmacovigilance Network in the Veneto Region.Prev Med Rep. 2024 Mar 29;41:102711. doi: 10.1016/j.pmedr.2024.102711. eCollection 2024 May. Prev Med Rep. 2024. PMID: 38606113 Free PMC article.
-
Immune thrombocytopenic purpura secondary to COVID-19 vaccination: A systematic review.Eur J Haematol. 2023 Apr;110(4):335-353. doi: 10.1111/ejh.13917. Epub 2022 Dec 30. Eur J Haematol. 2023. PMID: 36562217 Free PMC article.
-
Current Approaches to Vaccine Safety Using Observational Data: A Rationale for the EUMAEUS (Evaluating Use of Methods for Adverse Events Under Surveillance-for Vaccines) Study Design.Front Pharmacol. 2022 Mar 22;13:837632. doi: 10.3389/fphar.2022.837632. eCollection 2022. Front Pharmacol. 2022. PMID: 35392566 Free PMC article. Review.
-
Vaccine allergies.Clin Exp Vaccine Res. 2014 Jan;3(1):50-7. doi: 10.7774/cevr.2014.3.1.50. Epub 2013 Dec 18. Clin Exp Vaccine Res. 2014. PMID: 24427763 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources